Trademark: 97215981
Word
TD2 PRECISION ONCOLOGY
Status
Registered
Status Code
700
Status Date
Tuesday, August 22, 2023
Serial Number
97215981
Registration Number
7141897
Registration Date
Tuesday, August 22, 2023
Mark Type
3000
Filing Date
Wednesday, January 12, 2022
Published for Opposition
Tuesday, June 6, 2023

Trademark Owner History
TRANSLATIONAL DRUG DEVELOPMENT, LLC - Original Registrant

Classifications
42 Consulting services for others in the field of design, planning, and implementation of project management for scientific research, clinical trials, and statistical analyses in the field of oncology; Scientific research, namely, conducting pre-clinical trials and supporting clinical trials for others; Providing scientific research information in the field of pre-clinical testing; Pharmaceutical drug development and related services, namely, pharmaceutical products development and pharmaceutical research services
The mark consists of the words "TD2" with a symbol formed by circles of various sizes overlapping and sweeping to the left above the words "PRECISION ONCOLOGY".
TRANSLATIONAL DRUG TWO PRECISION ONCOLOGY; TRANSLATIONAL DRUG TO PRECISION ONCOLOGY
Color is not claimed as a feature of the mark.
"PRECISION ONCOLOGY"

Trademark Events
Aug 22, 2023
Notice Of Registration Confirmation Emailed
Aug 22, 2023
Registered-Principal Register
Jun 6, 2023
Official Gazette Publication Confirmation E-Mailed
Jun 6, 2023
Published For Opposition
May 17, 2023
Notification Of Notice Of Publication E-Mailed
May 3, 2023
Approved For Pub - Principal Register
Apr 8, 2023
Teas/Email Correspondence Entered
Apr 7, 2023
Correspondence Received In Law Office
Apr 7, 2023
Teas Response To Office Action Received
Oct 24, 2022
Notification Of Non-Final Action E-Mailed
Oct 24, 2022
Non-Final Action E-Mailed
Oct 24, 2022
Non-Final Action Written
Oct 19, 2022
Assigned To Examiner
Jan 20, 2022
Notice Of Design Search Code E-Mailed
Jan 19, 2022
New Application Office Supplied Data Entered
Jan 15, 2022
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24